Could a vaccine prevent Alzheimer's? early trial underway
NCT ID NCT06831812
First seen Feb 28, 2026 · Last updated May 15, 2026 · Updated 14 times
Summary
This early-stage study tested an experimental vaccine called AV-1959R in 16 healthy adults aged 40 to 60. The goal was to see if the vaccine is safe and can trigger an immune response against a protein linked to Alzheimer's disease. Participants received three shots over 14 weeks and were monitored for side effects and antibody levels. This research is a first step toward possibly preventing Alzheimer's with a vaccine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Arvax
Adelaide, Australia
Conditions
Explore the condition pages connected to this study.